We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App

Self-Expanding Peripheral Stent System Improves Implantation for Endovascular Treatments

By HospiMedica International staff writers
Posted on 28 Jul 2022
Print article
Image: Pulsar-18 T3 self-expanding peripheral stent system has received FDA approval (Photo courtesy of BIOTRONIK)
Image: Pulsar-18 T3 self-expanding peripheral stent system has received FDA approval (Photo courtesy of BIOTRONIK)

An innovative peripheral self-expanding stent system is designed to improve implantation procedures for endovascular treatments.

BIOTRONIK Inc.’s (Lake Oswego, OR, USA) Pulsar-18 T3 stent system uniquely combines three technologies. A 4-French low-profile delivery system may decrease the risk of access site complications and reduce the need for closure devices when compared to 6-French devices. The tri-axial system with braided shaft design facilitates stable and accurate implantation of the clinically proven Pulsar stent. With its thin struts and low chronic outward force (COF), the Pulsar-18 stent contributes to a reduced mean area of restenosis.

The redesigned Pulsar-18 T3 stent system offers physicians an intuitive and ergonomic wheel-operated handle for one-handed stent release enhancing the ability to control deployment. While the stent system has been redesigned with new features to enhance deployment, it builds on the established Pulsar stent performance. Data highlights the long-term safety and efficiency of the Pulsar stent, showing freedom from target lesion revascularization rate of 89.3% and no major target limb amputations at 24 months.

The Pulsar-18 T3 stent system is indicated for use to improve luminal diameter in patients with symptomatic de novo, restenotic or occlusive lesions located in the superficial femoral or proximal popliteal arteries, with reference vessel diameters from 3.0 to 6.0 mm and total lesion lengths up to 190 mm. BIOTRONIK will offer the Pulsar-18 T3 in up to a 200 mm stent length for treatment of long lesions.

"The Pulsar-18 T3 stent system is an innovative solution that delivers clinically proven performance – providing effective therapy that is easy to use for physicians while minimizing metal burden and may reduce the risk of restenosis for patients," stated David Hayes, M.D., Chief Medical Officer, BIOTRONIK, Inc.

"I was immediately impressed by the new concept of the Pulsar-18 T3 system," said Dr. Koen Deloose, Head of the Department of Vascular Surgery AZSint Blasius Hospital Dendermonde. "The combination of having a very ergonomic handle combined with a tri-axial system and also everything in a 4-French concept was, for me, quite unique."

Related Links:

Platinum Supplier
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Supplier
Ultrasound System
EEG Diagnostic Device
EEGDigiTrack multiEEG_42
Normothermia System

Print article


Critical Care

view channel
Image: The new blood test could prevent some of the 350,000 sepsis deaths in the U.S. annually (Photo courtesy of Cytovale)

Sepsis Test Could Save Lives in Emergency Departments, Study Suggests

Sepsis poses a severe, life-endangering illness that arises when an infection triggers a body-wide chain reaction, potentially causing multiple organs to fail quickly. Prompt and accurate diagnosis is... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The broad-spectrum POC coagulometer is well-suited for emergency room and emergency vehicle use (Photo courtesy of Perosphere)

Novel POC Coagulometer with Lab-Like Precision to Revolutionize Coagulation Testing

In emergency settings, when patients arrive with a bleed or require urgent surgery, doctors rely solely on clinical judgment to determine if a patient is adequately anticoagulated for reversal treatment.... Read more


view channel
Image: The global surgical lights market is expected to grow by close to USD 0.50 billion from 2022 to 2027 (Photo courtesy of Freepik)

Global Surgical Lights Market Driven by Increasing Number of Procedures

The global surgical lights market is set to witness high growth, largely due to the increasing incidence of chronic illnesses, a surge in demand for cosmetic and plastic surgeries, and untapped opportunities... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.